Myra L Patchen

Title: Inventor Myra L Patchen: Innovations in Constipation Treatment

Introduction

Myra L Patchen is an innovative inventor based in Fairfax Station, VA, recognized for her contributions to the field of pharmaceuticals. With a total of two patents to her name, Patchen has made significant strides in developing novel therapies aimed at improving human health, particularly in the treatment of constipation.

Latest Patents

Patchen's latest inventions include dosage units comprising a halogenated prostaglandin analog. These dosage units are designed specifically for treating constipation in human patients. The unique formulation not only provides relief from constipation but does so with minimal side effects. The dosage unit includes a prostaglandin (PG) analog represented by a specific formula, with a prescribed amount of 24 µg +/- 10%, ensuring its efficacy and safety for use.

Career Highlights

Myra Patchen's work at Sucampo AG has positioned her as a prominent figure in pharmaceutical research and development. Her innovative approach to drug formulation emphasizes the importance of combining therapeutic efficacy with patient safety, making her contributions invaluable to the industry. Through her patents, she showcases a commitment to improving the quality of life for those suffering from chronic constipation.

Collaborations

In her journey as an inventor, Patchen has collaborated with Ryuji Ueno, another expert in the field. Together, they have worked on developing effective pharmaceutical solutions that address gastrointestinal issues, reflecting a strong partnership in advancing medical science.

Conclusion

Myra L Patchen stands out as a notable inventor whose work has the potential to transform treatments for constipation. Her dedication to innovation and collaboration exemplifies the spirit of advancement in the pharmaceutical industry, paving the way for more effective and safer therapeutic options for patients.